Ethambutol Side Effects and Management

Introduction to Ethambutol Side Effects

The most serious side effect of ethambutol is retrobulbar neuritis, which can lead to vision loss that may be irreversible if the medication is not promptly discontinued when visual symptoms appear, as reported by the European Respiratory Journal and MMWR Recommendations and Reports 1, 2, 3

Retrobulbar neuritis is the most severe and concerning adverse effect, which is usually dose-related, according to the European Respiratory Journal and MMWR Recommendations and Reports 1, 2
Visual symptoms include decreased visual acuity, decreased red-green color discrimination, blurred vision, central scotomata, and peripheral visual field defects, as noted by MMWR Recommendations and Reports 2, 3
Risk of ocular toxicity increases significantly with higher doses, renal impairment, and treatment duration longer than 2 months, as reported by MMWR Recommendations and Reports and the European Respiratory Journal 1, 2, 3, 4
Peripheral neuritis in the legs is a rare adverse effect, according to the European Respiratory Journal and MMWR Recommendations and Reports 1, 3
Skin reactions requiring discontinuation occur in 0.2-0.7% of patients, as noted by MMWR Recommendations and Reports 3
Abdominal distress is a potential side effect, as reported by the European Respiratory Journal 1

Renal insufficiency significantly increases the risk of ocular toxicity, according to the European Respiratory Journal and MMWR Recommendations and Reports 1, 3
Doses exceeding 15 mg/kg/day increase the risk of toxicity, as reported by the European Respiratory Journal and MMWR Recommendations and Reports 1, 3
Extended treatment duration increases the risk of toxicity, as noted by MMWR Recommendations and Reports 3
Age, specifically the elderly, may be at higher risk, according to Thorax 5
Inability to report visual changes, such as in young children or cognitively impaired patients, increases the risk, as reported by the European Respiratory Journal and MMWR Recommendations and Reports 1, 3

Baseline visual acuity testing and color discrimination testing are recommended before starting treatment, as noted by MMWR Recommendations and Reports 3
Monthly monitoring of visual acuity and color discrimination is recommended for patients on high doses, with treatment duration longer than 2 months, or with renal insufficiency, according to MMWR Recommendations and Reports 3, 4
Renal function monitoring is recommended in patients with kidney disease, as reported by the European Respiratory Journal and MMWR Recommendations and Reports 1, 3
Measuring serum ethambutol levels is recommended in patients with renal dysfunction, as noted by Thorax 5, 6

Discontinue ethambutol immediately and permanently at the first sign of visual toxicity, as recommended by MMWR Recommendations and Reports 3
Dose adjustment is required in patients with renal disease, as noted by MMWR Recommendations and Reports 3
For end-stage renal disease patients on dialysis, administer at 15-20 mg/kg three times weekly after dialysis, as recommended by MMWR Recommendations and Reports 3

Known hypersensitivity to ethambutol is a contraindication, as reported by the European Respiratory Journal 1
Pre-existing optic neuritis from any cause is a contraindication, according to the European Respiratory Journal 1
Inability to report symptomatic visual disturbances is a contraindication, as noted by the European Respiratory Journal 1
Creatinine clearance <50 mL/min is a contraindication, as reported by the European Respiratory Journal 1
Use with caution in children whose visual acuity cannot be monitored, as recommended by MMWR Recommendations and Reports 3

Ethambutol can be used safely in patients with hepatic disease, as noted by MMWR Recommendations and Reports 3
Ethambutol is considered safe for use in pregnancy, according to MMWR Recommendations and Reports 3